From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.

In this episode of From the helm, Grady sits down with Neuren Pharmaceuticals (ASX:NEU) CEO Jon Pilcher, to recap on their major developments over the last 12 months in the US market, their guidance looking ahead for next financial year, and the company’s healthy cash balance. Find Bell Direct here: Twitter: https://twitter.com/belldirect Facebook: https://www.facebook.com/BellDirectAu... LinkedIn: https://www.linkedin.com/company/bell... Instagram: https://www.instagram.com/bell.direct/ Threads: https://www.threads.net/@bell.direct